Joseph M Miller
CIK 1746372 · Chief Financial Officer · last filed 2026-03-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$9.71M
Companies
4
Total Filings
27
Lifetime Open-Market Net
-$1.35M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AUPH | Chief Financial Officer | 613,932 | $15.82 | $9.71M | -$1.36M | 10 | 2026-03-03 |
| AVTX | Director | — | $14.76 | — | $0 | 3 | 2022-04-04 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Director | 40,582 | $2.93 | $118.9K | $10.8K | 13 | 2021-07-02 |
| Avalo Therapeutics, Inc. (CERCW) Delisted | Chief Financial Officer | 45,000 | — | — | $0 | 1 | 2018-07-16 |
Recent Filings · Page 2 of 3
27 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-04 | AVTX | Grant (A) | — | $0 | EDGAR |
| 2021-10-04 | AVTX | Grant (A) | — | $0 | EDGAR |
| 2021-07-02 | Avalo Therapeutics, Inc. (CERC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | Avalo Therapeutics, Inc. (CERC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-11 | AUPH | Buy (P) | +1,000 | $9.7K | EDGAR |
| 2021-04-02 | Avalo Therapeutics, Inc. (CERC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-05 | Avalo Therapeutics, Inc. (CERC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-10-01 | Avalo Therapeutics, Inc. (CERC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-01 | Avalo Therapeutics, Inc. (CERC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-19 | Avalo Therapeutics, Inc. (CERC) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.